No doubt such reports are very few and far-between and hard to find on the internet.
More detail in the print version obviously
India reviewing 700 serious post-vaccine adverse events
9 April, 2021
NEW DELHI: India is reviewing around 700 ‘severe and serious’ adverse events reported from across the country after Covid
vaccination in the light of global concerns over rare or unusual type of blood clots after receiving the AstraZeneca-Oxford University vaccine, officials said.
“We are monitoring the cases closely and relooking at some of the unusual technical parameters in the wake of the reports by the European regulator and the report by WHO raising concerns,” a senior official, member of the national committee on adverse events following immunisation (AEFI
TIMES VIEWIt would have been more prudent if such a step was taken earlier. Attributing deaths to comorbidities without proper investigation doesn’t improve public trust; rather it increases vaccine hesitancy. This is a welcome step towards transparency.
In India, experts are looking at adverse events from both Covishield and Bharat Biotech’s Covaxin.
To remind you: